ClearPoint Neuro第四季度每股收益$(0.20)未达$(0.16)预期,销售额$7.77M未达$8.23M预期

财报速递02-27
ClearPoint Neuro (NASDAQ:CLPT) 报告季度每股亏损$(0.20),未达到分析师共识预期的$(0.16),差异为25%。这比去年同期每股亏损$(0.19)减少了5.26%。公司报告季度销售额$7.77百万,未达到分析师共识预期$8.23百万,差异为5.57%。这比去年同期销售额$6.81百万增长了14.11%。

以上内容来自Benzinga Earnings专栏,原文如下:

ClearPoint Neuro (NASDAQ:CLPT) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate of $(0.16) by 25 percent. This is a 5.26 percent decrease over losses of $(0.19) per share from the same period last year. The company reported quarterly sales of $7.77 million which missed the analyst consensus estimate of $8.23 million by 5.57 percent. This is a 14.11 percent increase over sales of $6.81 million the same period last year.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法